论文部分内容阅读
目的探讨早期应用中小剂量尿激酶溶栓治疗急性脑梗死的临床疗效。方法将75例急性脑梗死患者分为观察组和对照组,制订疗效判定标准,然后两组均静脉滴注血塞通、丹参注射液及能量合剂,观察组加用尿激酶,短期应用。结果观察组疗效明显优于对照组。结论严格掌握溶栓治疗适应证、禁忌证,中小剂量尿激酶早期溶栓治疗急性脑梗死是安全、有效的。
Objective To investigate the early clinical application of small and medium dose urokinase thrombolytic therapy for acute cerebral infarction. Methods Seventy-five patients with acute cerebral infarction were divided into two groups: observation group and control group. Efficacy criteria were established. Then, Xuesaitong, Danshen injection and energy mixture were administered to both groups. Urokinase was added to the observation group for short-term application. Results The observation group was significantly better than the control group. Conclusion Strict grasp of indications for thrombolytic therapy, contraindication, early thrombolytic therapy of small and medium doses of acute cerebral infarction is safe and effective.